HIT Health In Tech, Inc.
Fundamentals / CIK 0002019505 / USDHealth In Tech, Inc. reported $30.92M in revenue and a net loss of $11.47M for the trailing twelve months ended September 30, 2026 (down 22.4% year over year), with a 50.5% gross margin and a -45.8% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open HIT in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$30.92M -22.4% YoY
-
Operating Income TTM-$14.16M -45.8% margin
-
Net Income TTM-$11.47M -37.1% net margin
-
Diluted EPS TTM-$0.18 Split-adjusted
-
Free Cash Flow TTM-- Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026-- Total debt: $84K
Annual revenue and net income
3 fiscal years (2023 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Revenue | $33.33M | $19.49M | $19.15M |
| Cost of Revenue | $12.39M | $4.05M | $2.30M |
| Gross Profit | $20.94M | $15.44M | $16.85M |
| Research & Development | $1.57M | $2.81M | $2.00M |
| Selling, General & Admin | $17.84M | $11.64M | $11.46M |
| Total Operating Expenses | $19.41M | $14.45M | $13.46M |
| Operating Income | $1.53M | $990K | $3.38M |
| EBITDA | $2.43M | $1.53M | $3.72M |
| Interest Income | $410K | $123K | $41K |
| Interest Expense | -- | $495K | $2.1K |
| Income Before Tax | $1.67M | $889K | $3.42M |
| Income Tax Expense | $395K | $219K | $945K |
| Net Income | $1.28M | $670K | $2.48M |
| Basic EPS | $0.02 | $0.01 | -- |
| Diluted EPS | $0.02 | $0.01 | -- |
| Basic Shares Outstanding | 55.8M | 51.8M | -- |
| Diluted Shares Outstanding | 57.7M | 53.7M | -- |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.59M | $8.06M | $8.77M | $7.51M | $8.49M | $9.31M | $8.01M | $4.90M |
| Cost of Revenue | $3.52M | $4.13M | $4.26M | $3.38M | $3.35M | $3.00M | $2.66M | $1.11M |
| Gross Profit | $3.06M | $3.92M | $4.51M | $4.13M | $5.14M | $6.31M | $5.36M | $3.80M |
| Research & Development | $939K | $876K | $920K | $213K | $236K | $583K | $538K | $634K |
| Selling, General & Admin | $5.18M | $6.48M | $5.75M | $4.09M | $4.42M | $5.00M | $4.34M | $3.48M |
| Total Operating Expenses | $11.45M | $7.36M | $6.67M | $4.30M | $4.65M | $5.58M | $4.87M | $4.11M |
| Operating Income | -$8.39M | -$3.44M | -$2.16M | -$171K | $494K | $725K | $481K | -$316K |
| EBITDA | -$8.11M | -$3.12M | -$1.75M | $240K | $712K | $861K | $617K | -$180K |
| Interest Income | $65K | $70K | $67K | $105K | $112K | $108K | $85K | $29K |
| Interest Expense | $20K | -- | -- | -- | -- | -- | -- | $0 |
| Income Before Tax | -$9.25M | -$3.32M | -$2.07M | -$444K | $600K | $833K | $684K | -$111K |
| Income Tax Expense | -$2.15M | -$810K | -$480K | -$141K | $148K | $203K | $186K | $33K |
| Net Income | -$7.07M | -$2.51M | -$1.59M | -$303K | $452K | $631K | $499K | -$144K |
| Basic EPS | -$0.11 | -$0.04 | -$0.03 | -- | $0.01 | $0.01 | $0.01 | -- |
| Diluted EPS | -$0.11 | -$0.04 | -$0.03 | -- | $0.01 | $0.01 | $0.01 | -- |
| Basic Shares Outstanding | 63.1M | 62.8M | 57.4M | -- | 56.4M | 55.4M | 54.6M | -- |
| Diluted Shares Outstanding | 63.1M | 62.8M | 57.4M | -- | 58.8M | 55.6M | 57.0M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Cash & Cash Equivalents | $7.67M | $7.85M | $2.42M |
| Cash & Short-Term Investments | $7.67M | $7.85M | $2.42M |
| Accounts Receivable, Net | $756K | $1.65M | $2.24M |
| Total Current Assets | $16.16M | $10.78M | $6.86M |
| Total Non-Current Assets | $6.93M | $4.98M | $4.64M |
| Total Assets | $23.09M | $15.77M | $11.50M |
| Other Current Liabilities | $892K | -- | -- |
| Total Current Liabilities | $5.16M | $2.13M | $4.78M |
| Total Non-Current Liabilities | $821K | $468K | $629K |
| Total Liabilities | $5.98M | $2.60M | $5.41M |
| Total Debt (incl. Leases) | $140K | $207K | $265K |
| Retained Earnings | $5.22M | $3.94M | $3.27M |
| Total Stockholders' Equity | $17.11M | $13.17M | $6.09M |
| Total Equity | $17.11M | $13.17M | $6.09M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | -- | $6.51M | $10.33M | $7.67M | $8.02M | $8.14M | $7.58M | $7.85M |
| Cash & Short-Term Investments | -- | $6.51M | $10.33M | $7.67M | $8.02M | $8.14M | $7.58M | $7.85M |
| Accounts Receivable, Net | $3.18M | $8.55M | $3.74M | $756K | $869K | $1.28M | $2.11M | $1.65M |
| Total Current Assets | $17.09M | $21.78M | $22.09M | $16.16M | $15.05M | $14.85M | $15.57M | $10.78M |
| Total Non-Current Assets | $10.94M | $7.85M | $6.88M | $6.93M | $7.71M | $7.32M | $5.76M | $4.98M |
| Total Assets | $28.03M | $29.63M | $28.97M | $23.09M | $22.76M | $22.18M | $21.33M | $15.77M |
| Other Current Liabilities | -- | -- | -- | $892K | $869K | $956K | $780K | -- |
| Total Current Liabilities | $15.15M | $9.99M | $7.05M | $5.16M | $5.24M | $5.39M | $6.75M | $2.13M |
| Total Non-Current Liabilities | $0 | $22K | $316K | $821K | $359K | $365K | $416K | $468K |
| Total Liabilities | $15.15M | $10.01M | $7.36M | $5.98M | $5.60M | $5.75M | $7.17M | $2.60M |
| Total Debt (incl. Leases) | $84K | $103K | $122K | $140K | $158K | $174K | $191K | $207K |
| Retained Earnings | -$5.95M | $1.12M | $3.63M | $5.22M | $5.52M | $5.07M | $4.44M | $3.94M |
| Total Stockholders' Equity | -- | -- | $21.60M | $17.11M | $17.16M | $16.42M | $14.16M | $13.17M |
| Total Equity | $12.88M | $19.62M | $21.60M | $17.11M | $17.16M | $16.42M | $14.16M | $13.17M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Net Income | $1.28M | $670K | $3.96M |
| Depreciation & Amortization | $901K | $541K | $339K |
| Stock-Based Compensation | $1.57M | $468K | -- |
| Change in Receivables | $907K | $587K | -$1.28M |
| Operating Cash Flow | $3.13M | $2.18M | $1.53M |
| Investing Cash Flow | -$3.13M | -$837K | -$1.94M |
| Common Stock Issued | -- | $8.21M | -- |
| Financing Cash Flow | -$187K | $4.09M | $1.34M |
| Net Change in Cash | -$179K | $5.43M | $928K |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$7.11M | -$2.51M | -$1.59M | -$303K | $452K | $631K | $499K | -$144K |
| Depreciation & Amortization | $279K | $320K | $403K | $411K | $218K | $136K | $136K | $136K |
| Stock-Based Compensation | $729K | $959K | $367K | $77K | $293K | $708K | $493K | -- |
| Change in Receivables | $3.48M | -$4.81M | -$2.98M | $130K | $417K | $823K | -$463K | -$716K |
| Operating Cash Flow | -$1.05M | -$2.91M | -$3.32M | $451K | $674K | $1.48M | $527K | -$531K |
| Investing Cash Flow | -$842K | -$597K | -$362K | -$768K | -$745K | -$910K | -$703K | -$542K |
| Common Stock Issued | $0 | $0 | $6.38M | -- | $0 | $0 | $8.21M | -- |
| Financing Cash Flow | $5.50M | -$301K | $6.34M | -$37K | -$44K | -$8.2K | -$98K | $7.18M |
| Net Change in Cash | $3.61M | -$3.81M | $2.66M | -$354K | -$115K | $563K | -$274K | $6.10M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Gross Margin | 62.8% | 79.2% | 88.0% |
| Operating Margin | 4.6% | 5.1% | 17.7% |
| Net Profit Margin | 3.8% | 3.4% | 12.9% |
| Return on Equity (ROE) | 7.5% | 5.1% | 40.6% |
| Return on Assets (ROA) | 5.5% | 4.3% | 21.5% |
| Current Ratio | 3.13x | 5.06x | 1.43x |
| Quick Ratio | 1.63x | 4.46x | 0.97x |
| Debt to Equity | 0.01x | 0.02x | 0.04x |
| Revenue Growth (YoY) | +71.0% | +1.8% | -- |
| Gross Profit Growth (YoY) | +35.6% | -8.4% | -- |
| Operating Income Growth (YoY) | +54.4% | -70.7% | -- |
| Net Income Growth (YoY) | +90.7% | -72.9% | -- |
| EPS Growth (YoY) | +100.0% | -- | -- |
| Operating Cash Flow Growth (YoY) | +44.0% | +42.3% | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 50.5% | 53.9% | 58.9% | 62.8% | 67.1% | 71.0% | 74.4% | 79.2% |
| Operating Margin | -45.8% | -16.1% | -3.3% | 4.6% | 4.5% | 5.0% | 5.1% | 5.1% |
| Net Profit Margin | -37.1% | -12.0% | -2.4% | 3.8% | 4.7% | 5.1% | 4.8% | 3.4% |
| Return on Equity (ROE) | -- | -- | -3.7% | 7.5% | 8.4% | 8.3% | 7.5% | 5.1% |
| Return on Assets (ROA) | -40.9% | -13.3% | -2.8% | 5.5% | 6.3% | 6.1% | 5.0% | 4.3% |
| Current Ratio | 1.13x | 2.18x | 3.13x | 3.13x | 2.87x | 2.76x | 2.31x | 5.06x |
| Quick Ratio | -- | 1.51x | 2.00x | 1.63x | 1.70x | 1.75x | 1.43x | 4.46x |
| Debt to Equity | -- | -- | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.02x |
| Revenue Growth (YoY) | -22.4% | -13.5% | +9.4% | +53.1% | +90.4% | +86.2% | +56.4% | -- |
| Gross Profit Growth (YoY) | -40.5% | -37.8% | -15.8% | +8.7% | +47.8% | +56.7% | +29.5% | -- |
| Operating Income Growth (YoY) | -1800.5% | -574.2% | -549.0% | -- | +12.5% | +35.5% | +44.6% | -- |
| Net Income Growth (YoY) | -1662.8% | -498.2% | -418.6% | -- | +20.2% | +86.6% | +395.9% | -- |
| EPS Growth (YoY) | -1200.0% | -500.0% | -400.0% | -- | 0.0% | 0.0% | -- | -- |
| Operating Cash Flow Growth (YoY) | -255.1% | -296.6% | -729.4% | -- | -68.2% | +17.0% | -- | -- |